| Enhanced tumor trafficking of GD2 chimeric antigen receptor T cells by expression of the chemokine receptor CCR2b JA Craddock, AN Lu, A Bear, M Pule, MK Brenner, CM Rooney, AE Foster Journal of immunotherapy 33 (8), 780-788, 2010 | 575 | 2010 |
| Challenges and opportunities for pancreatic cancer immunotherapy AS Bear, RH Vonderheide, MH O'Hara Cancer cell 38 (6), 788-802, 2020 | 359 | 2020 |
| Gold nanoparticle delivery of modified CpG stimulates macrophages and inhibits tumor growth for enhanced immunotherapy AY Lin, JP Mattos Almeida, A Bear, N Liu, L Luo, AE Foster, RA Drezek PloS one 8 (5), e63550, 2013 | 173 | 2013 |
| Elimination of metastatic melanoma using gold nanoshell-enabled photothermal therapy and adoptive T cell transfer AS Bear, LC Kennedy, JK Young, SK Perna, JP Mattos Almeida, AY Lin, ... PloS one 8 (7), e69073, 2013 | 157 | 2013 |
| T cells enhance gold nanoparticle delivery to tumors in vivo LC Kennedy, AS Bear, JK Young, NA Lewinski, J Kim, AE Foster, ... Nanoscale research letters 6, 1-11, 2011 | 126 | 2011 |
| High-density sub-100-nm peptide-gold nanoparticle complexes improve vaccine presentation by dendritic cells in vitro AY Lin, J Lunsford, AS Bear, JK Young, P Eckels, L Luo, AE Foster, ... Nanoscale Research Letters 8, 1-11, 2013 | 84 | 2013 |
| Replication-competent retroviruses in gene-modified T cells used in clinical trials: is it time to revise the testing requirements? AS Bear, RA Morgan, K Cornetta, CH June, G Binder-Scholl, ME Dudley, ... Molecular Therapy 20 (2), 246-249, 2012 | 77 | 2012 |
| Biochemical and functional characterization of mutant KRAS epitopes validates this oncoprotein for immunological targeting AS Bear, T Blanchard, J Cesare, MJ Ford, LP Richman, C Xu, ML Baroja, ... Nature communications 12 (1), 4365, 2021 | 65 | 2021 |
| Genetic modification of T cells with IL-21 enhances antigen presentation and generation of central memory tumor-specific cytotoxic T-lymphocytes AS Kaka, DR Shaffer, R Hartmeier, AM Leen, A Lu, A Bear, CM Rooney, ... Journal of immunotherapy 32 (7), 726-736, 2009 | 51 | 2009 |
| IRAK-M removal counteracts dendritic cell vaccine deficits in migration and longevity ME Turnis, XT Song, A Bear, AE Foster, S Gottschalk, MK Brenner, ... The Journal of Immunology 185 (7), 4223-4232, 2010 | 40 | 2010 |
| Tumor-derived myeloid cell chemoattractants and T cell exclusion in pancreatic cancer RH Vonderheide, AS Bear Frontiers in immunology 11, 605619, 2020 | 28 | 2020 |
| T cells as vehicles for cancer vaccination AS Bear, CR Cruz, AE Foster BioMed Research International 2011 (1), 417403, 2011 | 26 | 2011 |
| Expression of inducible factors reprograms CAR-T cells for enhanced function and safety A Smole, A Benton, MA Poussin, MA Eiva, C Mezzanotte, B Camisa, ... Cancer Cell 40 (12), 1470-1487. e7, 2022 | 21 | 2022 |
| Adoptive Cellular Therapy for Solid Tumors. AS Bear, JA Fraietta, VK Narayan, M O'Hara, NB Haas American Society of Clinical Oncology Educational book. American Society of …, 2021 | 20 | 2021 |
| Anti-tumor effects after adoptive transfer of IL-12 transposon-modified murine splenocytes in the OT-I-melanoma mouse model DL Galvan, RT O’Neil, AE Foster, L Huye, A Bear, CM Rooney, MH Wilson PLoS One 10 (10), e0140744, 2015 | 13 | 2015 |
| Low rate of infusional toxicity after expanded cord blood transplantation AS Bear, PJ Hanley, DM Bosque, CR Cruz, I Kaur, H Liu, P Kebriaei, ... Cytotherapy 16 (8), 1153-1157, 2014 | 13 | 2014 |
| An adaptable system for improving transposon-based gene expression in vivo via transient transgene repression JE Doherty, LE Woodard, AS Bear, AE Foster, MH Wilson The FASEB Journal 27 (9), 3753, 2013 | 10 | 2013 |
| Modified gold nanoparticles for therapy AE Foster, LB Carpin, AS Bear, R Drezek, AY Lin US Patent 20140086828A1 27, 2014 | 7 | 2014 |
| Concurrent nab-paclitaxel and radiotherapy: novel radiosensitization for borderline resectable or unresectable pancreatic cancer WT Arscott, KT Nead, A Bear, S Venigalla, J Shabason, JN Lukens, ... American Journal of Clinical Oncology 44 (9), 469-474, 2021 | 6 | 2021 |
| Modified gold nanoparticles for therapy AE Foster, LB Carpin, AS Bear, R Drezek, AY Lin US Patent App. 13/700,582, 2014 | 6 | 2014 |
